Home › Hemophilia › Pennsylvania › Harrisburg
Hemophilia clinical trials in Harrisburg, PA
3 studies for Hemophilia are looking for participants at sites in and around Harrisburg (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
RecruitingPhase 1Healthy volunteers welcome
- Penn State MS Hershey Med Ctr, Hershey · 12 mi away
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
RecruitingPhase 1Healthy volunteers welcome
- Penn State Milton S Hershey Medical Center Pediatrics, Hershey · 12 mi away
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
RecruitingPhase 1
- Penn State College of Medicine, Hershey · 12 mi away
About Hemophilia
Hemophilia is a rare disorder in which the blood does not clot normally. Usually hemophilia usually occurs in males and is inherited. Learn more.
More about Hemophilia on MedlinePlus
Hemophilia trials in other cities
- Indianapolis, IN9 studies
- Los Angeles, CA7 studies
- Seattle, WA6 studies
- Cedar Rapids, IA6 studies
- Philadelphia, PA5 studies
- Little Rock, AR5 studies
- Tampa, FL4 studies
- Sacramento, CA4 studies
- Dallas, TX4 studies
- Atlanta, GA4 studies
- Greenville, NC4 studies
- Orange, CA4 studies
Other studies in Harrisburg
- Heart Failure14 studies
- Breast Cancer12 studies
- Non-Small Cell Lung Cancer12 studies
- Cardiovascular Disease11 studies
- Lung Cancer9 studies
- Acute Myeloid Leukemia8 studies
- Prostate Cancer8 studies
- Colorectal Cancer7 studies
- Head and Neck Squamous Cell Carcinoma7 studies
- Neuroblastoma6 studies
- Crohn's Disease6 studies
- High Blood Pressure6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.